Rhenman & Partners Asset Management AB

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1599882 Stockholm, V7

Back to JAZZ Full portfolio

Position in JAZZ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$21,070,416

+$6,723,412 QoQ

Shares Held

87,440

+15.2% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

1.99%

of 13F equity value

Holder Rank

#88

of 629 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in JAZZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. JAZZ ranks #1 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc This page	87,440	$21,070,416
2	REGN	Regeneron Pharmaceuticals, Inc.	27,390	$17,078,760
3	BMRN	Biomarin Pharmaceutical Inc	290,500	$16,622,410
4	NRIX	Nurix Therapeutics, Inc.	684,250	$16,599,905
5	MIRM	Mirum Pharmaceuticals, Inc.	139,205	$16,296,729
6	INSM	INSMED Inc	151,960	$16,201,975
7	AXSM	Axsome Therapeutics, Inc.	63,050	$15,432,748
8	VRTX	Vertex Pharmaceuticals Inc / Ma	30,685	$15,242,160

All Filings in JAZZ

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,070,416	87,440	+15.2%	Shares	Sole	2026-08-13
2026-03-31	$14,347,004	75,890	+2.5%	Shares	Sole	2026-05-14
2025-12-31	$12,585,100	74,030	-22.1%	Shares	Sole	2026-02-13
2025-09-30	$12,524,954	95,030	-12.8%	Shares	Sole	2025-11-13
2025-06-30	$11,570,263	109,030	-12.3%	Shares	Sole	2025-08-13
2025-03-31	$15,431,845	124,300	-14.6%	Shares	Sole	2025-05-14
2024-12-31	$17,918,325	145,500	+56.5%	Shares	Sole	2025-02-13
2024-09-30	$10,361,130	93,000	-18.4%	Shares	Sole	2024-11-13
2024-06-30	$12,167,220	114,000	-22.3%	Shares	Sole	2024-08-13
2024-03-31	$17,669,106	146,729	+18.7%	Shares	Sole	2024-05-14
2023-12-31	$15,206,982	123,634	-13.9%	Shares	Sole	2024-02-13
2023-09-30	$18,591,984	143,634	-0.9%	Shares	Sole	2023-11-13
2023-06-30	$17,975,650	145,000	-3.3%	Shares	Sole	2023-08-11
2023-03-31	$21,949,500	150,000	+17.2%	Shares	Sole	2023-05-12
2022-12-31	$20,391,680	128,000	-2.7%	Shares	Sole	2023-02-13
2022-09-30	$17,527,635	131,500	-17.8%	Shares	Sole	2022-11-14
2022-06-30	$24,961,600	160,000	-12.1%	Shares	Sole	2022-08-12
2022-03-31	$28,328,203	181,976	-37.2%	Shares	Sole	2022-05-13
2021-12-31	$36,946,000	290,000	+3.6%	Shares	Sole	2022-02-11
2021-09-30	$36,458,800	280,000	+27.3%	Shares	Sole	2021-11-12
2021-06-30	$39,080,800	220,000	-12.0%	Shares	Sole	2021-08-13
2021-03-31	$41,092,500	250,000	+13.6%	Shares	Sole	2021-05-14
2020-12-31	$36,311,000	220,000	+29.4%	Shares	Sole	2021-01-19
2020-09-30	$24,240,300	170,000	+24.1%	Shares	Sole	2020-10-13
2020-06-30	$15,120,110	137,032	+14.2%	Shares	Sole	2020-07-16
2020-03-31	$11,968,800	120,000	—	Shares	Sole	2020-04-16
No filing history on record for this holder in this stock.